Stem Cell

(Image: Getty/CIPhotos)

Evotec licenses Ncardia’s disease modeling patents

By Melissa Fassbender

Ncardia has entered into a non-exclusive licensing agreement with Evotec through which the drug discovery solutions company will gain access to Ncardia’s stem cell derived cellular disease modeling IP.

Image: iStock/cacaroot

1st Stem Cell Community day in Germany

For stem cells 'the process is the product,' says Pluristem

By Dan Stanton

Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers